AbClon Balance Sheet Health
Financial Health criteria checks 2/6
AbClon has a total shareholder equity of ₩21.7B and total debt of ₩12.8B, which brings its debt-to-equity ratio to 59%. Its total assets and total liabilities are ₩40.6B and ₩18.9B respectively.
Key information
59.0%
Debt to equity ratio
₩12.80b
Debt
Interest coverage ratio | n/a |
Cash | ₩12.33b |
Equity | ₩21.69b |
Total liabilities | ₩18.89b |
Total assets | ₩40.58b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A174900's short term assets (₩14.7B) do not cover its short term liabilities (₩18.2B).
Long Term Liabilities: A174900's short term assets (₩14.7B) exceed its long term liabilities (₩641.7M).
Debt to Equity History and Analysis
Debt Level: A174900's net debt to equity ratio (2.2%) is considered satisfactory.
Reducing Debt: A174900's debt to equity ratio has increased from 8.2% to 59% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A174900 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A174900 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 17.5% each year